DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 74 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Alivus Life Sciences Limited — Analysts/Institutional Investor Meet/Con. Call Updates

NSE 1 hr ago·5 Sept 2026, 2:49 pm

Alivus Life Sciences

Alivus Life Sciences Limited has informed stock exchanges that it is scheduled to hold an Analyst/Institutional Investor Meet or a Conference Call. The company has released the schedule for this event, which will likely take place in the coming days.

This announcement is a routine corporate disclosure and does not itself indicate any specific news or financial results. However, such meetings are often used by companies to communicate their future growth strategy, product pipeline, or operational outlook to the investment community.

Investors should wait for the company's official updates and any insights shared during the meeting to understand the potential impact on the stock. For now, the market will likely view this simply as a scheduled informational session.